Cargando…
Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
We recently developed a mass spectrometry (MS) procedure based on the detection of a serum disaccharide (MS-DS) in patients with invasive candidiasis (IC). Here, we compare the performance of MS-DS for the diagnosis of IC, invasive aspergillosis (IA), and mucormycosis (MM) with those of commercially...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078558/ https://www.ncbi.nlm.nih.gov/pubmed/27605710 http://dx.doi.org/10.1128/JCM.01655-16 |
_version_ | 1782462405145526272 |
---|---|
author | Mery, Alexandre Sendid, Boualem François, Nadine Cornu, Marjorie Poissy, Julien Guerardel, Yann Poulain, Daniel |
author_facet | Mery, Alexandre Sendid, Boualem François, Nadine Cornu, Marjorie Poissy, Julien Guerardel, Yann Poulain, Daniel |
author_sort | Mery, Alexandre |
collection | PubMed |
description | We recently developed a mass spectrometry (MS) procedure based on the detection of a serum disaccharide (MS-DS) in patients with invasive candidiasis (IC). Here, we compare the performance of MS-DS for the diagnosis of IC, invasive aspergillosis (IA), and mucormycosis (MM) with those of commercially available antigen detection tests. This retrospective study included 48 patients (23 IC patients [74 serum samples], 15 IA patients [40 serum samples], and 10 MM patients [15 serum samples]) and 49 appropriate controls (102 serum samples). MS-DS, mannan (Mnn), galactomannan (GM), and (1,3)-β-d-glucan (BDG) were detected by matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) MS, Platelia, and Fungitell assays, respectively. For IC, the sensitivity and specificity of the MS-DS index, BDG detection, and Mnn detection were 62% and 84%, 82% and 60%, and 33% and 94% per serum sample and 83% and 69%, 96% and 31%, and 39% and 86% per patient, respectively. For IA, the corresponding values in comparison to BDG and GM detection were 83% and 81%, 62% and 95%, and 62% and 100% per serum sample and 93% and 76%, 87% and 90%, and 93% and 100% per patient, respectively. Nine of the 10 MM patients had a positive MS-DS result. MS-DS gave an early diagnosis in IC (73% positivity before blood culture), IA (positive before GM detection in six patients), and MM (positivity mainly preceded the date of diagnosis) patients. For IC, persisting MS-DS was associated with a poor prognosis. The different biomarkers were rarely detected simultaneously, suggesting different kinetics of release and clearance. For IA, MS-DS provided better complementation to GM monitoring than BDG monitoring. MS-DS detects panfungal molecules circulating during invasive fungal infections. The performance of MS-DS compared favorably with those of biological tests currently recommended for monitoring at-risk patients. Further validation of this test in multicenter studies is required. |
format | Online Article Text |
id | pubmed-5078558 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-50785582016-11-11 Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections Mery, Alexandre Sendid, Boualem François, Nadine Cornu, Marjorie Poissy, Julien Guerardel, Yann Poulain, Daniel J Clin Microbiol Mycology We recently developed a mass spectrometry (MS) procedure based on the detection of a serum disaccharide (MS-DS) in patients with invasive candidiasis (IC). Here, we compare the performance of MS-DS for the diagnosis of IC, invasive aspergillosis (IA), and mucormycosis (MM) with those of commercially available antigen detection tests. This retrospective study included 48 patients (23 IC patients [74 serum samples], 15 IA patients [40 serum samples], and 10 MM patients [15 serum samples]) and 49 appropriate controls (102 serum samples). MS-DS, mannan (Mnn), galactomannan (GM), and (1,3)-β-d-glucan (BDG) were detected by matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) MS, Platelia, and Fungitell assays, respectively. For IC, the sensitivity and specificity of the MS-DS index, BDG detection, and Mnn detection were 62% and 84%, 82% and 60%, and 33% and 94% per serum sample and 83% and 69%, 96% and 31%, and 39% and 86% per patient, respectively. For IA, the corresponding values in comparison to BDG and GM detection were 83% and 81%, 62% and 95%, and 62% and 100% per serum sample and 93% and 76%, 87% and 90%, and 93% and 100% per patient, respectively. Nine of the 10 MM patients had a positive MS-DS result. MS-DS gave an early diagnosis in IC (73% positivity before blood culture), IA (positive before GM detection in six patients), and MM (positivity mainly preceded the date of diagnosis) patients. For IC, persisting MS-DS was associated with a poor prognosis. The different biomarkers were rarely detected simultaneously, suggesting different kinetics of release and clearance. For IA, MS-DS provided better complementation to GM monitoring than BDG monitoring. MS-DS detects panfungal molecules circulating during invasive fungal infections. The performance of MS-DS compared favorably with those of biological tests currently recommended for monitoring at-risk patients. Further validation of this test in multicenter studies is required. American Society for Microbiology 2016-10-24 2016-11 /pmc/articles/PMC5078558/ /pubmed/27605710 http://dx.doi.org/10.1128/JCM.01655-16 Text en Copyright © 2016 Mery et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Mycology Mery, Alexandre Sendid, Boualem François, Nadine Cornu, Marjorie Poissy, Julien Guerardel, Yann Poulain, Daniel Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections |
title | Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections |
title_full | Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections |
title_fullStr | Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections |
title_full_unstemmed | Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections |
title_short | Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections |
title_sort | application of mass spectrometry technology to early diagnosis of invasive fungal infections |
topic | Mycology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078558/ https://www.ncbi.nlm.nih.gov/pubmed/27605710 http://dx.doi.org/10.1128/JCM.01655-16 |
work_keys_str_mv | AT meryalexandre applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections AT sendidboualem applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections AT francoisnadine applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections AT cornumarjorie applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections AT poissyjulien applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections AT guerardelyann applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections AT poulaindaniel applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections |